Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AfyaSTU:1AY 91 Days Payable is 59.90 as of Mar. 2026, which is 54% below its 10-year median of 129.62. GuruFocus rates STU:1AY with a GF Score™ of 91/100 and a GF Value™ of €18.46 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 210 Education companies, Afya ranks better than 67.62% on this metric.
Afya's average Accounts Payable for the
three
months ended in Mar. 2026 was €34.2 Mil. Afya's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €52.0 Mil.
Hence, Afya's Days Payable for the
three
months ended in Mar. 2026 was 59.90.
The historical rank and industry rank for Afya's Days Payable or its related term are showing as below:
STU:1AY'
s Days Payable Range Over the Past 10 Years
Min: 19.82 Med: 129.62 Max: 172.81
Current: 70.86
During the past 9 years, Afya's highest Days Payable was 172.81. The lowest was 19.82. And the median was 129.62.
STU:1AY's Days Payable is ranked better than 67.62% of 210
companies
in the Education industry
Industry Median: 34.365
vs STU:1AY: 70.86
Afya's Days Payable
declined
from Mar. 2025 (101.22) to Mar. 2026 (59.90).
It may suggest that Afyaaccelerated paying its suppliers.
Afya Days Payable Related Terms
Afya Days Payable Historical Data
* Premium members only.
The historical data trend for Afya's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:1AY vs DAO, PXED, LINC: Days Payable Comparison
For the Education & Training Services subindustry, Afya's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afya Days Payable vs Education Industry
For the Education industry and Consumer Defensive sector, Afya's Days Payable distribution charts can be found below:
* The bar in red indicates where Afya's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Afya's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Afya (STU:1AY) has a Days Payable of 59.90 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Afya and its competitors. This is 54% below median its historical median of 129.62. Over the past decade, Afya's Days Payable has ranged from 19.82 to 172.81. According to the industry distribution chart, Afya ranks #68 out of 210 companies in the Education industry, placing it in the top 32.4%.
Is Afya's Days Payable too high?
Afya's current Days Payable of 59.90 is 54% below median its 10-year median of 129.62. Over the past 10 years, this metric has ranged from a low of 19.82 to a high of 172.81. The Education industry median Days Payable is 34.37. Afya's value of 59.90 is 74.3% above this industry median. Based on the distribution chart, Afya ranks #68 out of 210 companies in the Education industry, which is above the industry midpoint. Overall, Afya has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Afya's Days Payable compare to DAO and PXED?
According to the Education industry distribution chart, Afya ranks #68 out of 210 companies for Days Payable. This puts Afya in the upper half of its industry. The industry median Days Payable is 34.37. Afya's value of 59.90 is 74.3% above this benchmark. Historically, Afya's own Days Payable has ranged from 19.82 to 172.81 over the past decade. While the company's 10-year median is 129.62 vs. the industry median of 34.37, Afya has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for an Education company?
The median Days Payable among Education companies is 34.37, based on 210 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afya's current Days Payable of 59.90 is 74.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Afya and its competitors. For the Education industry, the median Days Payable is 34.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afya's current Days Payable is 59.90, which is 54% below median its own 10-year median of 129.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afya stock overvalued right now?
Based on GuruFocus' analysis, Afya (STU:1AY) is currently considered Significantly Undervalued. The stock's GF Value™ is €18.46, compared to a current price of €12.20 — trading 33.9% below its estimated fair value. The current Days Payable is 59.90, which is 54% below median its 10-year median of 129.62 and 74.3% above the Education industry median of 34.37. Afya's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Afya (STU:1AY), the current Days Payable is 59.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afya (STU:1AY) Overvalued in 2026?
Based on GuruFocus' analysis, Afya stock appears to be undervalued.
The current stock price of €12.20 is trading 33.9% below its estimated GF Value™ of €18.46.
GuruFocus considers Afya to be Significantly Undervalued.
Key valuation signals for STU:1AY:
Days Payable: 59.90 (54% below median its 10-year median of 129.62)
GF Value™: €18.46 vs. price of €12.20 (33.9% below fair value)
Industry Position: 74.3% above the Education median (#68 of 210)
No single metric tells the full story. See the STU:1AY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
91GF Score
Get the complete analysis for STU:1AY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:1AY has been successfully added to your 
